Aconitum carmichaeli Debx. is a traditional Chinese medicine commonly employed for curing a wide array of diseases in East Asia. From the ethyl acetate soluble fraction of the methanolic extracts of A. carmichaeli, a new alkaloid, aconitamide (1), along with eighteen known compounds 2-19 were isolated by column chromatography and identified on the basis of spectroscopic analyses. The anti-telomerase activity of 1-19 was also assessed, but no activity was found, even at a concentration higher than 30 M.
The roots of Aconitum carmichaeli Debx. (Ranunculaceae), termed "Fuzi" or " Chuanwu" in Chinese, is proved to be an essential component in the formulations of Chinese traditional medicine [1a,b] . Its pharmacological effects were reported to result from the presence of diterpene alkaloids [1c]; some related alkaloids, such as aconitine, mesaconitine and hypaconitine were found to be highly toxic [2a] . From the authentic processed plant materials, a previously unreported benzanilide, aconitamide (1) (Figure 1 ), together with eighteen non-alkaloidal compounds (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) were isolated and identified in this study.
Compound 1, amorphous white powder, molecular formula C 15 H 13 NO 6 {HREIMS: [M] + (m/z = 303.0751)}, indicating a double bond equivalence (DBE) of ten. The IR absorptions at 3349, 1621, 1543 and 1457 cm -1 indicated the presence of hydroxyl, conjugated -COO-or -CONH-, and an aromatic moiety, respectively. Fifteen carbon resonances observed in the 13 C NMR spectrum in acetone-d 6 ( Table 1) of 1 were attributable to one methoxy at C 53.2 (-OCH 3 ), two carbonyl carbons at  C 169.3 (C-7′) and 168.9 (C-7), and two aromatic moieties at 155.8 (C-2), 154.0 (C-5′), 150.5 (C-5), 133.7 (C-2′), 123.5 (C-4, -3′), 122.3 (C-4′), 119.8 (C-3), 118.5 (C-1′), 117.5 (C-6′), 116.0 (C-1) and 112.3 (C-6) ( Table 1) . The 1 H NMR spectrum exhibited signals for one methyl ester attached to an aromatic ring group [ H 3.97 (s, Ar-COOCH 3 )], which exhibited a HMBC correlation with one carbonyl signal at  C 169.3 (C-7′), and two sets of ABX-type coupled aromatic protons [ H 8.56 (d, J = 9.2 Hz, H-3′), 7.54 (d, J = 3.2 Hz, H-6′) and 7.16 (dd, J = 9.2, 3.2 Hz, H-4′), and 7.28 (d, J = 2.8 Hz, H-6), 7.04 (d, J = 8.8, 2.8 Hz, H-4) and 6.83 (d, J = 8.8 Hz, H-3)], as well as four down field shifted singlet signals for two strong hydrogen bonded protons and two phenol protons at  H 11.74, 11.55, 8.83 and 8.42 (Table 1) Figure 1B) , HO-5 ( H 8.83)/C-4′ and C-5′; H-6′ ( H 7.54, d, J = 3.2)/C-2′, C-4′ and C-7′ ( C 169.3, ester carbonyl group), and H-3′/C-1′ and C-5′ revealed that the methyl ester was located at C-1′, and H-6′ was located between -OH and -COOMe. A residual quaternary carbon at  C 133.7 was then reasonably assigned to connect with the N-atom of the amide group. This secondary amide was determined to be located ortho to the methyl ester, which caused strong hydrogen bonding between -NH ( H 11.74) and the carbonyl of the ester. Two carbonyl groups were thus fixed with two strong hydrogen bonds, and which made H-3′ downshifted to H 8.56. Also, in 6a,12a-dihydro--toxicarol [2b], one phenyl proton presented at  H 8.25 due to the anisotropic effect of the carbonyl group. When compound 1 was measured in CD 3 OD (Table 1) , four signals at  H 11. 74, 11.55, 8.83, 8 .42 from X-H (X = O, N) all disappeared. Accordingly, the structure of 1 was deduced.
Compound 2 was comprised of myristic, palmitic, and stearic acids [3a] , their respective contents being determined as 1:6 
Extraction and isolation:
The roots of A. carmichaeli (18.0 kg) were extracted with methanol (40 L x 3) at room temperature. Evaporation of the solvent from the extracts under reduced pressure gave the crude residue (560 g), which was subjected to partition using ethyl acetate, n-butanol and water, successively. The EtOAc part (50 g) was pre-absorbed with 80 g SiO 2 and then subjected to CC on silica gel (1500 g) using n-hexane with increasing amounts of EtOAc as eluent to afford 12 fractions denoted as fractions I-XII by monitoring with TLC. Repeated chromatography of the fractions I-IV (12.5 g) with n-hexane/EtOAc (100% → 95%) and purification of each compound by HPLC afforded 2 (32.1 mg), 3 (15.3 mg) , 4 (23.4 mg) and 5 (16.3 mg). Fraction V (2.5 g) was rechromatographed on a silica gel 60 column (230-400 mesh) with nhexane/EtOAc (90:10), followed by HPLC to yield 6 (14.5 mg) and 7 (34.6 mg). Fraction VI (5.3 g) was re-chromatographed on a silica gel 60 column with n-hexane/EtOAc (80:20), followed by HPLC afforded 8 (18.3 mg), 9 (10.5 mg), 10 (24.6 mg), 11 (8.9 mg), 12 (3.6 mg), 13 (6.7 mg), 14 (22.5 mg), 15 (12.0 mg), 16 (7.8 mg) and 17 (5.6 mg) . Fraction VII (1.5 g) was re-chromatographed on a silica gel 60 column with n-hexane/EtOAc (70:30), followed by HPLC to give 1 (3.4 mg), 18 (7.4 mg) and 19 (4.5 mg).
Aconitiamide (1) 
Anti-telomerase activity assay:
All the isolated compounds were tested for anti-telomerase activity using the method [5] , but inactive even at a concentration higher than 30 M.
